Personalising pancreas cancer treatment: When tissue is the issue. - Wikidata - awgldk - TriplyDB

Personalising pancreas cancer treatment: When tissue is the issue.

Personalising pancreas cancer treatment: When tissue is the issue.

http://www.wikidata.org/entity/Q33801384

about

FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.The need for effective pancreatic cancer detection and management: a biomarker-based strategy.Pancreatic cancer tissue banks: where are we heading?A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma.Basaloid carcinoma of the pancreas--clinicopathological presentation and oncogenetic snapshot of a rare entity.The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.

P2860

Q28075540-DB5D3640-4C78-46DC-BF74-014758C81B34 Q33803923-A03EDB87-25B6-41CA-B43E-7D5EBAE0E268 Q38591066-ECDBE834-285B-4FE7-9F4D-A43A70648DE6 Q38829844-45595F50-F195-4021-97D4-42ACEF8E3C62 Q42017784-8E89C496-B16D-486A-8910-B30C18C2267A Q43452290-F2FA29D6-66B7-4A48-B8B5-4C099098E777 Q48098689-42890DE5-F995-4A6C-BB21-E42AB3F3E904

P2860

Personalising pancreas cancer treatment: When tissue is the issue.

http://www.wikidata.org/entity/Q33801384

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Personalising pancreas cancer treatment: When tissue is the issue.

@ast

Personalising pancreas cancer treatment: When tissue is the issue.

@en

type

label

Personalising pancreas cancer treatment: When tissue is the issue.

@ast

Personalising pancreas cancer treatment: When tissue is the issue.

@en

prefLabel

Personalising pancreas cancer treatment: When tissue is the issue.

@ast

Personalising pancreas cancer treatment: When tissue is the issue.

@en

P1433

Q33801384-1F803155-798C-4D9A-9126-36ABB45353F0

P1476

Q33801384-5DD5F054-ADE1-4AD0-8A6A-3DC435640889

P2093

Q33801384-02825FE0-2A27-4786-AF13-684E7FABA7F9

Q33801384-56E1BA36-3D0D-4300-A794-C8FBA21F3A6C

Q33801384-5A31B081-5775-4FED-ABC7-BB536407FF05

Q33801384-887829BB-B50C-46EB-8383-799CC32902A9

Q33801384-F7438D09-2066-4BF2-90C5-062FB3B2D925

P2860

Q33801384-026181C8-9F3A-477B-9EA3-F3E0A596AE1E

Q33801384-0F2A0C47-13A4-4E55-AEC2-FCFC4B636F2D

Q33801384-1787F3F7-13C5-4458-9FBE-B2F8CAAA9FAA

Q33801384-17E6F328-BFEC-49EE-A9D9-5CA0E5D0105A

Q33801384-1AA90C1D-77E8-4927-B9A5-D6C161C9BABB

Q33801384-1CE6B229-5181-485C-B9D8-CCFCEE326ACF

Q33801384-1F7DF71C-0F43-40AA-84A1-2479733998E7

Q33801384-22EC2E68-DBBA-439F-9B33-93E47A36145A

Q33801384-240A0201-D1BD-4AAA-8944-6A1615B6E1D8

Q33801384-269817A4-E828-4D59-BF79-671AECF72347

P304

Q33801384-3BEDCD0F-5AD1-4C06-A489-67635324124C

P31

Q33801384-784B1F8E-19DA-469D-B148-D18DDB17D14B

P356

Q33801384-EED274D1-0D68-4B2B-ADE9-3439C1E77163

P407

Q33801384-0E53D051-F0A1-49B0-B0E5-B2EC83505C6E

P433

Q33801384-D52B87E3-0B79-445A-8BAD-EE29940BAA6A

P478

Q33801384-60E8BBF2-1BC2-4BB8-BAFF-AA653F233D5A

P50

Q33801384-1121F6BB-09B0-4BBB-A278-228F7FA991DA

Q33801384-2A028DF2-E666-46EF-A4DE-6C4F61296CE1

Q33801384-4AB3BEEF-7C72-420B-8BAA-18BFEAB2CAA9

Q33801384-6A079EE8-D677-4F94-B7D7-B2823717D316

Q33801384-779CE678-7323-442E-B977-1397D9215949

Q33801384-9FEAEF83-F9D2-4539-B6FE-D4F4B066AD97

Q33801384-DE71111F-CAF5-428F-B01A-4807B03AE707

P577

Q33801384-BC3102B1-E99E-4645-BE1A-8D3B8DFB828B

P5875

Q33801384-DFE72B8D-F369-4B59-8432-3603474CCDBC

P698

Q33801384-2F0BFE51-4D27-4E41-9639-590092B73005

P921

Q33801384-3F603297-C6DB-446A-9F5B-12117D1CEEA4

P932

Q33801384-5093E9D8-824E-4654-A3CD-1F0BF5B65258

P356

WJG.V20.I24.7849

P1433

World Journal of Gastroenterology

P1476

Personalising pancreas cancer treatment: When tissue is the issue.

@en

P2093

Adnan M Nagrial

http://www.w3.org/2001/XMLSchema#string

Amber L Johns

http://www.w3.org/2001/XMLSchema#string

Angela Chou

http://www.w3.org/2001/XMLSchema#string

Chelsie O'Connor

http://www.w3.org/2001/XMLSchema#string

Chris Hemmings

http://www.w3.org/2001/XMLSchema#string

P2860

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Efficient tumour formation by single human melanoma cells

Determination of stromal signatures in breast carcinoma.

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.

Cancer statistics, 2013

P304

7849-7863

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I24.7849

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Katrin Sjoquist

Lorraine A Chantrill

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263514381

http://www.w3.org/2001/XMLSchema#string

P698

24976722

http://www.w3.org/2001/XMLSchema#string

P921

Aizkuņģa dziedzeris

P932

4069313

http://www.w3.org/2001/XMLSchema#string